about
Primary and secondary patient data in contrast: the use of observational studies like RABBITHealth-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.Sustainability of rituximab therapy in different treatment strategies: results of a 3-year followup of a German biologics register[How do register data support clinical decision-making?].Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis.Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohortsFrequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years[Good Practice Data Linkage]
P50
Q28067885-0C25DF6A-59E0-48D5-BF62-796AD8E40487Q30957102-7CEB0D5C-1D41-4AFC-9ADF-CE68B3FAE9FDQ34803197-86C50F37-AAAF-4317-882C-C5A87BC1EBF3Q35585867-82FF1D06-CAB8-4806-BED4-1347DC10688EQ37031387-AE6C0D03-7358-4969-8723-40C5646D0B71Q37156561-FF8F06D0-CE8B-40FC-AFA3-955095D87594Q37235732-C9CAE057-0AD8-4271-ACA3-7E66577B1A2AQ48599341-E12E7AA6-7A2F-49F8-B9B4-5067B6BCA71CQ57493327-4CA2D868-10DF-4FF3-B519-76E116E3CB85Q91343605-C14B7498-3159-4ADB-840D-2FADCD3F07E6Q92502058-41B1B1D8-F392-482B-9577-91572CCB31A1
P50
description
researcher (ORCID 0000-0002-3372-2021)
@en
name
Adrian Richter
@en
type
label
Adrian Richter
@en
prefLabel
Adrian Richter
@en
P31
P496
0000-0002-3372-2021